• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Multiple sclerosis-like lesions and type I interferon signature in a patient with RVCL.

作者信息

Schuh Elisabeth, Ertl-Wagner Birgit, Lohse Peter, Wolf Waltraud, Mann Johannes F, Lee-Kirsch Min Ae, Hohlfeld Reinhard, Kümpfel Tania

机构信息

Institute of Clinical Neuroimmunology (E.S., R.H., T.K.) and Institute of Clinical Radiology (B.E.-W.), Ludwig-Maximilians University, Munich, Germany; Department of Neuroimmunology (E.S.), Center of Brain Research, Vienna, Austria; Institute of Laboratory Medicine and Human Genetics (P.L.), Singen, Germany; Department of Ophthalmology (W.W.), Outpatient Clinic Neuhann, Munich, Germany; Department of Nephrology (J.F.M.), Clinical Centre Schwabing, Munich, Germany; Department of Pediatrics (M.A.L.-K.), Technische Universität Dresden, Germany; and Munich Cluster for Systems Neurology (SyNergy) (R.H.), Munich, Germany.

出版信息

Neurol Neuroimmunol Neuroinflamm. 2014 Dec 23;2(1):e55. doi: 10.1212/NXI.0000000000000055. eCollection 2015 Feb.

DOI:10.1212/NXI.0000000000000055
PMID:25566545
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4277301/
Abstract
摘要

相似文献

1
Multiple sclerosis-like lesions and type I interferon signature in a patient with RVCL.伴有视网膜血管病变合并脑白质病变的患者出现多发性硬化样病变及I型干扰素特征
Neurol Neuroimmunol Neuroinflamm. 2014 Dec 23;2(1):e55. doi: 10.1212/NXI.0000000000000055. eCollection 2015 Feb.
2
A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis.单核细胞中 I 型干扰素特征与多发性硬化症患者对干扰素-β反应不佳相关。
Brain. 2009 Dec;132(Pt 12):3353-65. doi: 10.1093/brain/awp228.
3
A robust type I interferon gene signature from blood RNA defines quantitative but not qualitative differences between three major IFNβ drugs in the treatment of multiple sclerosis.血液RNA中强大的I型干扰素基因特征定义了三种主要IFNβ药物在治疗多发性硬化症时的定量差异而非定性差异。
Hum Mol Genet. 2015 Jun 1;24(11):3192-205. doi: 10.1093/hmg/ddv071. Epub 2015 Feb 26.
4
Relevance of the type I interferon signature in multiple sclerosis towards a personalized medicine approach for interferon-beta therapy.I型干扰素特征在多发性硬化症中对β-干扰素治疗个性化医疗方法的相关性。
Discov Med. 2013 Jan;15(80):51-60.
5
In vitro development of goat-sheep and goat-goat zona-free cloned embryos in different culture media.不同培养液中山羊-绵羊和山羊-山羊去透明带克隆胚胎的体外发育。
Theriogenology. 2014 Feb;81(3):419-23. doi: 10.1016/j.theriogenology.2013.10.013. Epub 2013 Oct 18.
6
Multiple sclerosis: interferon beta for some serious forms.多发性硬化症：某些严重形式使用β-干扰素。
Prescrire Int. 2007 Dec;16(92):252-7.
7
The use of cytokine signature patterns: separating drug naïve, interferon and natalizumab-treated multiple sclerosis patients.细胞因子特征模式的应用：区分未使用过药物、接受过干扰素和那他珠单抗治疗的多发性硬化症患者。
Autoimmunity. 2014 Dec;47(8):505-11. doi: 10.3109/08916934.2014.930734. Epub 2014 Jun 30.
8
Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).肌肉注射干扰素β-1a治疗复发型多发性硬化症的疾病进展。多发性硬化症协作研究组（MSCRG）。
Ann Neurol. 1996 Mar;39(3):285-94. doi: 10.1002/ana.410390304.
9
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta.达利珠单抗治疗活跃期复发型多发性硬化症（CHOICE 研究）：一项干扰素 β 附加治疗的 2 期、随机、双盲、安慰剂对照的研究
Lancet Neurol. 2010 Apr;9(4):381-90. doi: 10.1016/S1474-4422(10)70033-8. Epub 2010 Feb 15.
10
A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis.一项干扰素β-1b 治疗原发性进展型和复发缓解型-进展型多发性硬化症的单中心、随机、双盲、安慰剂对照研究。
Mult Scler. 2009 Oct;15(10):1195-205. doi: 10.1177/1352458509106937. Epub 2009 Sep 29.

引用本文的文献

1
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations in conjunction with systemic lupus erythematosus: Missed diagnosis or misdiagnosis?视网膜血管病变伴脑白质病和全身表现合并系统性红斑狼疮：漏诊还是误诊？
Immun Inflamm Dis. 2024 Aug;12(8):e1367. doi: 10.1002/iid3.1367.
2
Modeling of age-related neurological disease: utility of zebrafish.与年龄相关的神经疾病建模：斑马鱼的效用
Front Aging Neurosci. 2024 May 3;16:1399098. doi: 10.3389/fnagi.2024.1399098. eCollection 2024.
3
Author Response: Teaching NeuroImage: Partially Reversible Widespread Leukoencephalopathy Associated With Atypical Hemolytic Uremic Syndrome.

本文引用的文献

1
Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study.干扰素相关生物标志物在 TREX1、RNASEH2A、RNASEH2B、RNASEH2C、SAMHD1 和 ADAR 基因突变相关的 Aicardi-Goutières 综合征中的评估：病例对照研究。
Lancet Neurol. 2013 Dec;12(12):1159-69. doi: 10.1016/S1474-4422(13)70258-8. Epub 2013 Oct 30.
2
Chronic exposure of astrocytes to interferon-α reveals molecular changes related to Aicardi-Goutieres syndrome.星形胶质细胞慢性暴露于干扰素-α揭示了与 Aicardi-Goutières 综合征相关的分子变化。
Brain. 2013 Jan;136(Pt 1):245-58. doi: 10.1093/brain/aws321.
3
作者回复：教学神经影像：与非典型溶血尿毒综合征相关的部分可逆性广泛性白质脑病。
Neurology. 2023 Oct 24;101(17):770. doi: 10.1212/WNL.0000000000207893.
4
Kidney-Predominant Thrombotic Microangiopathy Associated With Frameshift Mutation.与移码突变相关的以肾脏为主的血栓性微血管病
Kidney Int Rep. 2023 Aug 4;8(10):2172-2176. doi: 10.1016/j.ekir.2023.07.024. eCollection 2023 Oct.
5
Type I Interferonopathies in Childhood.儿童 1 型干扰素病。
Balkan Med J. 2023 May 8;40(3):165-174. doi: 10.4274/balkanmedj.galenos.2023.2023-4-78.
6
Interferon in systemic lupus erythematosus-A halfway between monogenic autoinflammatory and autoimmune disease.系统性红斑狼疮中的干扰素——介于单基因自身炎症性疾病和自身免疫性疾病之间。
Heliyon. 2022 Nov 24;8(11):e11741. doi: 10.1016/j.heliyon.2022.e11741. eCollection 2022 Nov.
7
Retinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic manifestations (RVCL-S): An update on basic science and clinical perspectives.伴有脑白质脑病及全身表现的视网膜血管病变（RVCL-S）：基础科学与临床观点的最新进展
Cereb Circ Cogn Behav. 2022 Feb 14;3:100046. doi: 10.1016/j.cccb.2022.100046. eCollection 2022.
8
Monogenic Autoinflammatory Diseases: State of the Art and Future Perspectives.单基因自身炎症性疾病：现状与未来展望。
Int J Mol Sci. 2021 Jun 14;22(12):6360. doi: 10.3390/ijms22126360.
9
Serial magnetic resonance imaging changes of pseudotumor lesions in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations: a case report.视网膜血管病伴脑白质病和全身表现的假性肿瘤病变的连续磁共振成像改变：病例报告。
BMC Neurol. 2021 Jun 9;21(1):219. doi: 10.1186/s12883-021-02250-4.
10
Type I Interferonopathies in Children: An Overview.儿童I型干扰素病概述
Front Pediatr. 2021 Mar 31;9:631329. doi: 10.3389/fped.2021.631329. eCollection 2021.
Evolution of a tumor-like lesion in cerebroretinal vasculopathy and TREX1 mutation.
脑视网膜血管病变中肿瘤样病变的演变与TREX1突变
Neurology. 2010 Sep 28;75(13):1211-3. doi: 10.1212/WNL.0b013e3181f4d7ac.
4
Clinical and molecular phenotype of Aicardi-Goutieres syndrome.艾卡迪-古铁雷斯综合征的临床和分子表型
Am J Hum Genet. 2007 Oct;81(4):713-25. doi: 10.1086/521373. Epub 2007 Sep 4.
5
C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy.人类3'-5' DNA核酸外切酶TREX1的C末端截短会导致伴有脑白质营养不良的常染色体显性视网膜血管病变。
Nat Genet. 2007 Sep;39(9):1068-70. doi: 10.1038/ng2082. Epub 2007 Jul 29.
6
Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus.编码3'-5' DNA核酸外切酶TREX1的基因突变与系统性红斑狼疮相关。
Nat Genet. 2007 Sep;39(9):1065-7. doi: 10.1038/ng2091. Epub 2007 Jul 29.
7
Cerebroretinal vasculopathy mimicking a brain tumor: a case of a rare hereditary syndrome.酷似脑肿瘤的脑视网膜血管病变：一例罕见遗传性综合征病例
Neurology. 1999 Aug 11;53(3):629-31. doi: 10.1212/wnl.53.3.629.